HOME >> BIOLOGY >> NEWS
UC develops new approach to Web-based drug withdrawal warnings

CINCINNATI -- The University of Cincinnati (UC) has developed a faster approach for informing consumers online when the Food and Drug Administration (FDA) withdraws a medication.

The new approach works with NetWellness.org, a commercial-free, consumer health Web site produced by Ohio's three medical research universities--UC, Case Western Reserve University and Ohio State University.

"Information about drug withdrawals may not reach patients quickly enough to prevent potentially dangerous side effects," explains Peter Embi, MD, lead author on the UC-based study published in the most recent online edition of the Journal of Medical Internet Research. "Given the public's growing use of the Web for health information, it's important that Web-based consumer health content is kept up to date, particularly that involving withdrawal of a potentially harmful medicine.

"However," says Embi, assistant professor of medicine and a researcher at UC's Institute for the Study of Health, "it's been shown that many sites don't update their content for days, or even weeks, following an FDA drug withdrawal.

"Our new approach," he says, "allows just one person to modify affected Web pages in less than an hour and within just hours of an FDA drug withdrawal announcement."

Embi says he hopes this new method will encourage those responsible for other Web sites carrying critical consumer health information to adopt a similar 24-hour response standard to drug withdrawals.

"There's evidence that patients continue to use medications for some time after their withdrawal, which occasionally causes harmful effects," Embi explains, "so it's important to inform the public as quickly as possible."

Before developing the new approach, Embi and his team evaluated NetWellness' previous update process following the FDA's withdrawal of the painkilling, anti-inflammatory drug Vioxx (rofecoxib) on Sept. 30, 2004.

Notifie
'"/>

Contact: Jill Hafner
jill.hafner@uc.edu
513-558-4639
University of Cincinnati
25-Sep-2006


Page: 1 2 3

Related biology news :

1. N.C. A&T food scientist develops process for allergen-free peanuts
2. MIT develops nanoparticles to battle cancer
3. Engineer ramps up protein production, develops versatile viral spheres
4. Hopkins develops online tool to aid research on certain orphan diseases
5. U of I scientist develops enzyme inhibitor that may slow cancer growth
6. West develops taste for primates
7. OHSU researcher develops first animal model to treat devasting head and neck cancers
8. Novel stem cell technology develops a new cell for repairing spinal cord injuries
9. Interdisciplinary team develops guidelines for treating severely injured patients
10. Georgia Tech develops technology for more compact, inexpensive spectrometers
11. Carnegie Mellon develops non-invasive technique to detect transplant rejection at cellular level

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/21/2019)... , ... May 20, 2019 , ... ... health care field, today announced a 96.15% pass rate for first-time test takers ... This surpasses the national average of 76.43% by nearly 20 points. , ...
(Date:5/14/2019)... (PRWEB) , ... May 14, 2019 , ... ... expansion of their business strategy beyond immuno-oncology into areas of autoimmunity, fibrosis and ... T cell and tumor cell lines for IO discovery efforts. , IMMUNE ...
(Date:5/8/2019)... ... May 08, 2019 , ... RG+A, Inc., ... Carol S. Mann has agreed to serve as Chief Executive Officer and pharmaceutical ... Officer, effective immediately. They will join Chairman and Founder Roger Green to create ...
Breaking Biology News(10 mins):
(Date:4/15/2019)... ... April 15, 2019 , ... Sirrus, Inc., a developer of ... plant expansion to increase production of methylene malonate monomers and oligomers. , The ... Sirrus’ full-scale production facility, which is scheduled to break ground in 2019. “The ...
(Date:4/9/2019)... ... April 09, 2019 , ... Sonny Bar Lisa, or Sonny for short, is ... months. After a series of diagnostics, an MRI was performed which revealed Sonny ... the injury and found that VetStem Regenerative Cell Therapy may be a ...
(Date:4/4/2019)... ... 2019 , ... Biomeme, Inc. , a leading manufacturer ... solution for performing PCR, RT-PCR, qPCR, and Isothermal tests called Franklin ™. ... an English chemist and X-ray crystallographer who made significant contributions to the understanding ...
(Date:3/27/2019)... ... March 27, 2019 , ... Lachman is sponsoring the event on April 1-4, ... Dublin, Ireland. The executive team on site will be available to discuss strategies and ... the agenda this year. , Executives from Lachman participating at this year’s conference include ...
Breaking Biology Technology:
Cached News: